These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2177314)

  • 1. [Non-A, non-B hepatitis: hepatitis C].
    de Moura MC
    Acta Med Port; 1990; 3(4):209-12. PubMed ID: 2177314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The hepatitis C virus--principal causative agent in non-A, non-B hepatitis].
    Schaff Z; Lapis K
    Orv Hetil; 1990 Sep; 131(35):1903-6. PubMed ID: 2170894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.
    Dienstag JL; Alter HJ
    Semin Liver Dis; 1986 Feb; 6(1):67-81. PubMed ID: 3012784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positive rate of serum anti-HCV in various liver diseases and the clinico-pathological study of chronic liver disease in alcoholics].
    Sugimoto M; Iizuka T; Sato T; Sadamoto T; Abei T; Nonaka H
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):349-59. PubMed ID: 1663337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C.
    Sherlock DS
    Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
    Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
    Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C.
    Alter MJ
    Arch Pathol Lab Med; 1994 Apr; 118(4):342-5. PubMed ID: 7513149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental studies of hepatitis C virus: a review].
    Fujiyama S; Kawano S
    Rinsho Byori; 1992 Sep; 40(9):911-7. PubMed ID: 1331574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
    Imamura S
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis virus C: from discovery to applications in public health].
    Trépo C
    Rev Prat; 1990 Jun; 40(18):1631-9. PubMed ID: 2115200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tolA antibody in non-A, non-B chronic liver disease.
    Nakamuta M; Sugimura T; Kotoh K; Fukutomi T; Sakamoto S; Yamamoto M; Nawata H
    Fukuoka Igaku Zasshi; 1992 Oct; 83(10):367-76. PubMed ID: 1281459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post-transfusion non-A, non-B hepatitis: is a specific test in sight?].
    Kühnl P; Sibrowski W; Böhm BO
    Beitr Infusionsther; 1989; 24():60-8. PubMed ID: 2481550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of hepatitis C virus antibody in chronic HBsAg-negative non alcoholic hepatopathy].
    Bárcena Marugán R; Nash R; Pascasio JM; Sáez de Santa-María J; Avilés J; García Hoz F; Moreira VF; Cano A; Milicua JM; Graus J
    Rev Esp Enferm Dig; 1992 Feb; 81(2):117-20. PubMed ID: 1314634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C].
    Krarup HB; Krogsgaard K
    Ugeskr Laeger; 1994 Jul; 156(28):4129-34. PubMed ID: 8066908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
    Sugiyasu T
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
    Seeff LB; Hollinger FB; Alter HJ; Wright EC; Cain CM; Buskell ZJ; Ishak KG; Iber FL; Toro D; Samanta A; Koretz RL; Perrillo RP; Goodman ZD; Knodell RG; Gitnick G; Morgan TR; Schiff ER; Lasky S; Stevens C; Vlahcevic RZ; Weinshel E; Tanwandee T; Lin HJ; Barbosa L
    Hepatology; 2001 Feb; 33(2):455-63. PubMed ID: 11172349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.